|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||291.88 - 292.90|
|52-week range||291.88 - 292.90|
|Beta (5Y monthly)||1.35|
|PE ratio (TTM)||0.98|
|Earnings date||26 Oct 2022 - 31 Oct 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Abiomed (NASDAQ: ABMD), a maker of medical devices that provide circulatory support, including the Impella heart pumps used in cardiac surgery, saw its shares climb 18.4% in July, according to data from S&P Global Intelligence. Abiomed's price-to-earnings ratio of 97.05 may be considered high by some, but that's misleading because of its continued growth. Abiomed's quarterly revenue has climbed 108.7% over the past five years, and its recent quarterly reports show that trend isn't slowing.
Today we're going to take a look at the well-established Abiomed, Inc. ( NASDAQ:ABMD ). The company's stock saw a...
Abiomed's (ABMD) strength in Impella product revenues drives its Q1 top line.